The Pennant Group, Inc.
NASDAQ:PNTGMedical - Care Facilities
-$0.83 today
- Market cap
- $1.26B
- Beta
- 1.27
- P/E (TTM)
- 38.6
- EPS (TTM)
- $0.87
Volume 0.43M
Average 0.25M
PNTG Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
The Pennant Group, Inc.NASDAQ: PNTG
Gross Profit · Q1 FY2026 · quarter ended Mar 2026
Gross profit grows, but more slowly than its trailing trend
Q1 FY2026 gross profit of $37.4M rose 27.3% year over year, behind the +47.4% change in trailing-twelve-month gross profit. Sequentially, it fell 0.1% from the prior quarter. Over 3 fiscal years it compounded at +27.9% a year.
Context
- Gross profit amounted to 12.9% of revenue in FY2025, down 0.6 pp from a year earlier.
- Gross profit increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +27.3% toward the trailing-twelve-month pace of +47.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 122.47M USD
- Year-over-year change
- +30.6%
- 4-year CAGR
- +26.0%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 122.47M | +30.6% |
| FY2024 | 2024-12-31 | 93.76M | +39.9% |
| FY2023 | 2023-12-31 | 67.04M | +14.4% |
| FY2022 | 2022-12-31 | 58.59M | +20.6% |
| FY2021 | 2021-12-31 | 48.6M | — |
Gross Profit vs competitors
How PNTG compares with its peers on the latest reported figures
- PNTG's LTM Mar 2026 gross profit of $151.28M is the 10th highest of the 11 companies compared; the peer median is $641.34M.
- Its year-over-year change of +47.4% is the highest of 11, against a peer median of +8.9%.
- Gross profit amounts to 14.8% of revenue for PNTG, versus a peer median of 30.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.72B | +13.3% | +13.5% | 43.9% | |
| LTM Jun 2026 | $1.09B | +33.2% | +42.5% | 19.7% | |
| LTM Oct 2026 | $858.25M | +12.0% | +13.3% | 32.1% | |
| LTM Jun 2026 | $789.96M | -6.5% | -0.3% | 30.4% | |
| LTM Jun 2026 | $775.91M | +5.9% | +15.6% | 14.1% | |
| LTM Sep 2026 | $506.78M | -12.4% | +15.4% | 32.0% | |
| LTM Jun 2026 | $477.75M | +15.1% | +15.5% | 32.4% | |
| LTM Sep 2026 | $426.54M | -49.7% | +7.9% | 14.5% | |
| LTM Mar 2026 | $196.25M | +31.8% | +62.9% | 20.7% | |
| LTM Mar 2026 | $151.28M | +47.4% | +27.9% | 14.8% | |
| LTM Mar 2026 | -$123.06M | -136.6% | — | 29.9% | |
| Peer median (excluding PNTG) | $641.34M | +8.9% | +15.4% | 30.2% | |
Competitors are the stored peer set for PNTG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 439.69M | 473.24M | 544.89M | 695.24M | 947.71M |
| Cost of Revenue | 391.1M | 414.66M | 477.86M | 601.48M | 825.24M |
| Gross Profit | 48.6M | 58.59M | 67.04M | 93.76M | 122.47M |
| Gross Margin | 11.1% | 12.4% | 12.3% | 13.5% | 12.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 36.26M | 33.98M | 36.67M | 50.21M | 71.08M |
| Operating Expenses | 43.9M | 45.85M | 41.87M | 55.65M | 71.08M |
| Depreciation & Amortization | 4.78M | 4.9M | 5.13M | 6.12M | 8.54M |
| EBITDA | 9.46M | 17.61M | 30.64M | 44.44M | 60.85M |
| EBITDA Margin | 2.2% | 3.7% | 5.6% | 6.4% | 6.4% |
| Operating Income | 4.7M | 12.74M | 25.17M | 38.12M | 51.39M |
| Operating Margin | 1.1% | 2.7% | 4.6% | 5.5% | 5.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.94M | 3.82M | 5.92M | 6.96M | 6.68M |
| Other Income / Expenses | (1.97M) | (3.85M) | (5.59M) | (6.75M) | (5.76M) |
| Income Before Tax | 2.73M | 8.89M | 19.58M | 31.37M | 45.63M |
| Pre-Tax Margin | 0.6% | 1.9% | 3.6% | 4.5% | 4.8% |
| Income Tax Expense | 582K | 1.65M | 5.67M | 7.03M | 11.87M |
| Net Income | 2.7M | 6.64M | 13.38M | 22.56M | 29.58M |
| Net Margin | 0.6% | 1.4% | 2.5% | 3.2% | 3.1% |
| EPS (Basic) | 0.08 | 0.23 | 0.45 | 0.72 | 0.86 |
| EPS (Diluted) | 0.07 | 0.22 | 0.44 | 0.71 | 0.84 |
| Weighted Avg Shares | 28.41M | 29.06M | 29.86M | 31.19M | 34.56M |
| Weighted Avg Shares (Diluted) | 30.64M | 30.16M | 30.19M | 32M | 35.32M |
The Pennant Group, Inc.
NASDAQ:PNTG
Intrinsic Alpha fair value
Locked
Current Price
$35.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.